MedTrace Logo

Relationships Among FVIII, t-PA/PAI-1, and MMP-9 Levels and Intracranial Hemorrhage Complications After Thrombolysis With Alteplase in Patients With Acute Ischemic Stroke: Protocol for a Multicenter Retrospective Study

NCT03733223 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2019-03-19

No results posted yet for this study

Summary

The primary aim of the study is to investigate the relationships among FVIII, t-PA/PAI-1, MMP-9 levels, and intracranial hemorrhage after thrombolysis with alteplase using a combined analysis.

Conditions

Interventions

DRUG

Ateptidase

Treatment of ischemic stroke with Ateptidase

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER

  • First Affiliated Hospital of Jinan University

    collaborator OTHER

  • Zhujiang Hospital

    lead OTHER

Principal Investigators

  • Shuai He, Doctor · Southern Medical University, China

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-12
Primary Completion
2020-06-30
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03733223 on ClinicalTrials.gov